With Medtronic Driver bare-metal stent in comparison, show results of this study have a lower rate of target vessel failure treatment for patients with the Endeavor stent – primarily due to a reduced rate of target vessel revascularization . TVF is a composite of TVR, myocardial infarction and cardiac death http://acyclovirpills.org/ .
The long-termII four-year results showing Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting StentToday at EuroPCR, Medtronic , four-year data published from the ENDEAVOR II study, the amplified. The long-term safety and durable efficacy of the company’s Endeavor zotarolimus – eluting coronary stent system for the treatment of coronary heart disease – Because the duration of follow-up in ENDEAVOR II grows, so too does our confidence in the continued safety and efficacy of the Endeavor stent, said Dr. Jean Fajadet the Clinique Pasteur Unit? de Cardiologie intervention Nelle in Tolouse, France, who presented the data in the Late-Breaking Clinical Trials session. The shelf life of this device performance is remarkable based on these four-year results showing low late side effects. .
The British Psychological Society Annual Conference at the Holiday Inn on Brighton 1 to 3 April 2009th.